Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is ...

It has been a banner year for biotech buyouts, and these are two of the prime targets.

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.

In interviews as well as a panel at BIO’s annual meeting, investors and life sciences bankers predicted an acceleration in ...

It might pull it off, provided several things fall right in place.

Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...

Biotechnology is enjoying one of its strongest years in recent times, which is mostly fueled by a rebound in capital markets, ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

After years in the wilderness, this overlooked ASX biotech stock is winning back believers, with some analysts tipping gains ...

Neuren shares are soaring after a major European regulatory breakthrough brought its lead drug one step closer to a lucrative ...